Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Pharmacol Ther. 2022 Jan 30;234:108119. doi: 10.1016/j.pharmthera.2022.108119

Table 4. Effect of Therapeutic Strategies on the Blood-Brain Barrier in AD Models.

Table 4 lists studies indicated in Figure 6 that show the effects of therapeutics strategies in transgenic AD mice and rats. References: (Batarseh, et al., 2017; Batarseh & Kaddoumi, 2018; Beckmann, Gerard, Abramowski, Cannet, & Staufenbiel, 2011; Bien-Ly, et al., 2015; Blockx, et al., 2016; Burbach, et al., 2007; Burgess, Dubey, et al., 2014; Burgess, Nhan, Moffatt, Klibanov, & Hynynen, 2014; Chauhan & Sandoval, 2007; Chauhan, Siegel, & Lichtor, 2004; J. J. Choi, et al., 2008; Cortes-Canteli, et al., 2019; Dubey, et al., 2020; Elfakhri, et al., 2019; Fan, DeFilippis, & Van Nostrand, 2007; Faraco, et al., 2016; Fitz, et al., 2014; Hattori, et al., 2016; Herring, et al., 2010; Hur, et al., 2018; Jordao, et al., 2010; Jordao, et al., 2013; Kook, et al., 2014; Lazic, et al., 2019; W. J. Lee, et al., 2020; Leinenga & Gotz, 2018; Leinenga, Koh, & Gotz, 2019; M. Liu, et al., 2018; X. Liu, et al., 2019a, 2019b; Lynch, et al., 2021; Marinescu, et al., 2017; Michael, et al., 2019; Mueggler, et al., 2003; Nyul-Toth, et al., 2020; Ongali, et al., 2014; Pandit & Mukhopadhyay, 2004; Y. H. Park, et al., 2020; Passos, Kilday, Gillen, Cribbs, & Vasilevko, 2016; Poduslo, Curran, Wengenack, Malester, & Duff, 2001; Poon, Pellow, & Hynynen, 2021; Reuter, Venus, Grudzenski, et al., 2016; Robison, et al., 2020; Royea, Martinot, & Hamel, 2020; Saito, Buciak, Yang, & Pardridge, 1995; Schultheiss, et al., 2006; Shabir, et al., 2020; Sharp, et al., 2019; J. Song, Choi, Whitcomb, & Kim, 2017; St-Amour, et al., 2013; Takeda, et al., 2009; Thakker, et al., 2009; Uekawa, et al., 2016; Van Skike, et al., 2018; Vasilevko, Xu, Previti, Van Nostrand, & Cribbs, 2007; Weber-Adrian, et al., 2019; Xhima, et al., 2020; Xie, et al., 2020; Xiong, et al., 2021; M. Xu, et al., 2020; J. Yan, et al., 2015; P. Yan, et al., 2015).

# In Fig. 6 Therapeutic Strategy Model Reference
1 Angiotensin Receptor Blockers Tg2576 Mice Nyül-Töth et al. 2020; Passos et al. 2016; Faraco et al. 2016
2 Angiotensin Receptor Blockers APP23 Mice Takeda et al. 2009
3 Angiotensin Receptor Blockers hAPP (J20) Mice Ongali et al. 2014; Royea et al. 2020
4 Angiotensin Receptor Blockers TgSwDI Mice Faraco et al. 2016
5 Angiotensin Receptor Blockers 5xFAD Mice Uekawa et al. 2016
6 Antibiotics Tg2576 Mice hAPP (J20) Mice Yan et al. 2015
7 Antibiotics Tg2576 Mice hAPP (J20) Mice Van Skike et al. 2018
8 Antibiotics TgSwDI Mice Fan et al. 2007
9 Antibiotics 5xFAD Mice Yan et al. 2015
10 Anticoagulants Tg2576 Mice Micheal et al. 2019
11 Anticoagulants APP23 Mice Marinescu et al. 2017
12 Anticoagulants TgCRND8 Mice Cortes-Canteli et al. 2019
13 Anticoagulants 5xFAD Mice Lazic et al. 2019
14 Antioxidants Tg2576 Mice Park et al. 2020; Han et al. 2015
15 Antioxidants APP23 Mice Liu et al. 2019a; Liu et al. 2019b
16 Antioxidants TgSwDI Mice Saito et al. 2017
17 Antioxidants APP/PS1 Mice Xu et al 2020
18 Antioxidants 5xFAD Mice Elfakhri et al 2019; Batarseh & Kaddoumi, 2018; Song et al. 2017; Batarseh et al. 2017; Kook et al. 2014
19 Cranial / Cognitive Stimulations APP23 Mice Mueggler et al. 2003
20 Cranial / Cognitive Stimulations hAPP (J20) Mice Shabir et al. 2020; Sharp et al. 2019
21 Cranial / Cognitive Stimulations TgCRND8 Mice Herring et al. 2010
22 Cranial / Cognitive Stimulations TgSwDI Mice Robison et al. 2020
23 Immunosuppressants hAPP (J20) Mice Van Skike et al. 2018
24 Passive Immunotherapies PDAPP Mice Blockx et al. 2016
25 Passive Immunotherapies Tg2576 Mice Thakker et al. 2009
26 Passive Immunotherapies APP23 Mice Burbach et al. 2007; Fitz et al. 2014; Beckmann et al. 2011
27 Passive Immunotherapies TgCRND8 Mice Dubey et al. 2020; Jordäo et al. 2010; Chauhan, 2007; Chauhan et al. 2004
28 Passive Immunotherapies TgSwDI Mice Vasilevko et al. 2007
29 Passive Immunotherapies 3xTg-AD St-Amour et al. 2013
30 Passive Immunotherapies Tau P301L Mice Bien-Ly et al. 2015
31 Passive Immunotherapies APP/PS1 Mice Podulso et al. 2001
32 Passive Immunotherapies 5xFAD Mice Xiong et al. 2021
33 Scanning / Focused Ultrasound APP23 Mice Leinenga et al. 2019; Leinenga & Götz, 2018 Poon et al. 2021; Lynch et al. 2021; Dubey et al. 2020
34 Scanning / Focused Ultrasound TgCRND8 Mice Liu et al. 2018; Burgess et al. 2014a; Burgess et al. 2014b; Jordäo et al. 2013; Jordäo et al. 2010; Xhima et al. 2020; Weber-Adrian et al. 2019;
35 Scanning / Focused Ultrasound Tau P301L Mice Pandit et al. 2019
36 Scanning / Focused Ultrasound APP/PS1 Mice Choi et al 2008
37 Scanning / Focused Ultrasound 5xFAD Mice Lee et al. 2020
38 Short-Chain Fatty Acids Tg2576 Mice Hur et al. 2018
39 Short-Chain Fatty Acids APP23 Mice Reuter et al 2016
40 Short-Chain Fatty Acids APP/PS1 Mice Xie et al. 2020
41 Statins & NSAIDs Tg2576 Mice Garcia-Alloza et al. 2009
42 Statins & NSAIDs APP23 Mice Reuter et al. 2016; Schultheiss et al. 2006
43 Statins & NSAIDs TgSwDI Mice Hattori et al. 2016